Agilent Technologies, Inc. $A Shares Sold by Advisors Capital Management LLC

Advisors Capital Management LLC cut its holdings in Agilent Technologies, Inc. (NYSE:A) by 1.9% in the 2nd quarter, according to its most recent 13F filing with the SEC. The fund owned 61,103 shares of the medical research company’s stock after selling 1,167 shares during the period. Advisors Capital Management LLC’s holdings in Agilent Technologies were worth $7,211,000 at the end of the most recent reporting period.

Other large investors also recently made changes to their positions in the company. Resona Asset Management Co. Ltd. increased its holdings in Agilent Technologies by 6.2% in the 2nd quarter. Resona Asset Management Co. Ltd. now owns 98,400 shares of the medical research company’s stock valued at $11,631,000 after purchasing an additional 5,767 shares in the last quarter. TrueMark Investments LLC acquired a new position in shares of Agilent Technologies during the second quarter worth about $1,999,000. Fenimore Asset Management Inc boosted its position in shares of Agilent Technologies by 2.7% in the second quarter. Fenimore Asset Management Inc now owns 180,880 shares of the medical research company’s stock worth $21,346,000 after buying an additional 4,823 shares during the period. Asset Management One Co. Ltd. grew its stake in shares of Agilent Technologies by 3.4% in the second quarter. Asset Management One Co. Ltd. now owns 124,577 shares of the medical research company’s stock valued at $14,701,000 after buying an additional 4,152 shares in the last quarter. Finally, Brighton Jones LLC grew its stake in shares of Agilent Technologies by 89.5% in the second quarter. Brighton Jones LLC now owns 9,068 shares of the medical research company’s stock valued at $1,070,000 after buying an additional 4,284 shares in the last quarter. Hedge funds and other institutional investors own 87.41% of the company’s stock.

Insider Buying and Selling

In other Agilent Technologies news, CEO Padraig Mcdonnell sold 12,490 shares of the stock in a transaction that occurred on Wednesday, November 12th. The stock was sold at an average price of $150.00, for a total transaction of $1,873,500.00. Following the transaction, the chief executive officer owned 33,448 shares of the company’s stock, valued at $5,017,200. This trade represents a 27.19% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. 0.26% of the stock is currently owned by corporate insiders.

Analyst Ratings Changes

A number of equities analysts have weighed in on A shares. Weiss Ratings restated a “hold (c)” rating on shares of Agilent Technologies in a report on Wednesday, October 8th. JPMorgan Chase & Co. boosted their target price on shares of Agilent Technologies from $155.00 to $165.00 and gave the stock an “overweight” rating in a research report on Thursday, October 9th. Evercore ISI raised their price target on shares of Agilent Technologies from $128.00 to $140.00 and gave the company an “in-line” rating in a report on Tuesday, October 7th. Wells Fargo & Company lifted their price target on shares of Agilent Technologies from $140.00 to $150.00 and gave the stock an “overweight” rating in a research note on Monday, September 15th. Finally, Rothschild & Co Redburn assumed coverage on shares of Agilent Technologies in a research report on Wednesday, October 8th. They issued a “buy” rating and a $165.00 price objective for the company. One investment analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating and six have assigned a Hold rating to the company’s stock. According to data from MarketBeat, Agilent Technologies currently has a consensus rating of “Moderate Buy” and a consensus price target of $149.62.

Agilent Technologies Stock Up 0.0%

A stock opened at $146.90 on Friday. The company has a current ratio of 2.25, a quick ratio of 1.71 and a debt-to-equity ratio of 0.53. The firm has a 50 day simple moving average of $137.63 and a 200-day simple moving average of $123.77. The company has a market capitalization of $41.65 billion, a P/E ratio of 34.48, a PEG ratio of 4.67 and a beta of 1.29. Agilent Technologies, Inc. has a twelve month low of $96.43 and a twelve month high of $153.84.

Agilent Technologies (NYSE:A) last posted its quarterly earnings data on Wednesday, August 27th. The medical research company reported $1.37 EPS for the quarter, meeting analysts’ consensus estimates of $1.37. The firm had revenue of $1.74 billion for the quarter, compared to the consensus estimate of $1.67 billion. Agilent Technologies had a net margin of 17.97% and a return on equity of 25.51%. The firm’s revenue was up 10.1% compared to the same quarter last year. During the same period in the prior year, the firm posted $1.32 EPS. Agilent Technologies has set its FY 2025 guidance at 5.560-5.590 EPS. Q4 2025 guidance at 1.570-1.600 EPS. On average, equities research analysts predict that Agilent Technologies, Inc. will post 5.58 earnings per share for the current fiscal year.

Agilent Technologies Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Wednesday, October 22nd. Investors of record on Tuesday, September 30th were issued a $0.248 dividend. This represents a $0.99 annualized dividend and a yield of 0.7%. The ex-dividend date of this dividend was Tuesday, September 30th. Agilent Technologies’s payout ratio is currently 23.24%.

Agilent Technologies Company Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.